Loading
Latest filing published 03 Feb 2016 for Windtree Therapeutics INC. Read the official filing
No signal scores available.
John A. Tattory discloses dealings in Windtree Therapeutics Inc to SEC (Form 4). In total, 2 filings cover trades dated from 30 September 2015 to 31 December 2015.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 3 February 2016 with a share grant in Windtree Therapeutics Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations